Unique ID issued by UMIN | UMIN000020412 |
---|---|
Receipt number | R000023572 |
Scientific Title | Association of serum and sputum resistin like molecule-beta(RELM-beta) with airway remodeling in bronchial asthma |
Date of disclosure of the study information | 2015/12/31 |
Last modified on | 2017/03/18 11:53:06 |
Association of serum and sputum resistin like molecule-beta(RELM-beta) with airway remodeling in bronchial asthma
Association of serum and sputum resistin like molecule-beta(RELM-beta) with airway remodeling in bronchial asthma
Association of serum and sputum resistin like molecule-beta(RELM-beta) with airway remodeling in bronchial asthma
Association of serum and sputum resistin like molecule-beta(RELM-beta) with airway remodeling in bronchial asthma
Japan |
bronchial asthma
Pneumology |
Others
NO
To measure the correlation between the concentration of sputum supernatant and serum RELM-beta and the index of airway wall thickness on chest CT in bronchial asthma
Others
To measure the correlation between the concentration of sputum supernatant and serum RELM-beta and the index of airway wall thickness on chest CT in bronchial asthma
The correlation between the concentration of sputum supernatant and serum RELM-beta and the index of airway wall thickness on chest CT in bronchial asthma
Observational
20 | years-old | <= |
99 | years-old | >= |
Male and Female
Object: stable asthmatic patients
Control: patients undergoing routine chest CT for small nodules or small gland glass opacities in peripheral lung
(early lung cancer and atypical adenomatous hyperplasia) without airway disease such as asthma
If patients meet the following criteria, they are excluded.
Patients who
i. have respiratory tract infection or other respiratory disease within 4 weeks prior to enrollment
ii. have asthma attacks within 4 weeks prior to enrollment
iii. use anti-allergy drugs or inhaled anticholinergic drugs within 2 weeks prior to enrollment
iv. use systemic corticosteroids within 4 weeks prior to enrollment
v. currently smoke, had smoking history with 5 pack-years or more, or had quitted smoking within 6 months prior to the enrollment
vi. prepare for pregnancy, in pregnancy or breast-feeding
vii. unsuitable for the study
40
1st name | |
Middle name | |
Last name | Masaya Takemura |
Nagoya City University
Dept of Respiratory Medicine, Allergy and Clinical Immunology
1 kawasumi, mizuho-cho, mizuho-ku, Nagoya, Aichi, Japan
052-853-8216
m-take19@med.nagoya-cu.ac.jp
1st name | |
Middle name | |
Last name | Hiroya Ichikawa |
Nagoya City University
Dept of Respiratory Medicine, Allergy and Clinical Immunology
1 kawasumi, mizuho-cho, mizuho-ku, Nagoya, Aichi, Japan
052-853-8216
cartgreengreengreen@gmail.com
Nagoya City University
Self funding
Self funding
NO
2015 | Year | 12 | Month | 31 | Day |
Unpublished
Completed
2015 | Year | 04 | Month | 08 | Day |
2015 | Year | 04 | Month | 08 | Day |
2017 | Year | 03 | Month | 18 | Day |
2017 | Year | 03 | Month | 18 | Day |
2017 | Year | 03 | Month | 18 | Day |
2017 | Year | 03 | Month | 18 | Day |
Design
cross-sectional study
Enrollment
patients who met the criteria of this study will be enrolled between Apr 2015 and Mar 2016
Measurement items
levels of RELM-beta in serum and sputum supernatant and indices of airway remodeling on chest CT
2015 | Year | 12 | Month | 31 | Day |
2017 | Year | 03 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023572
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |